Promoting Diabetes Equity: A Vision for Diabetes 20/20

Diabetes is a large and growing public health emergency, especially among people of color and the poor who face serious co-morbidities such as heart and kidney disease, limited access and/or connection to primary care, poor adherence, and as a result, repeated episodes of costly hospitalization. 40% of adults living with diabetes are in the Medicare Fee-for-Service program, concentrated in 7500 zip codes in the U.S. Sustainable Healthy Communities (SHC) is working with partners to address the needs of this population and achieve the triple aim of good care, outcomes, and controlled costs.

Diabetes Advisory Group Roundtable

In March of 2017, SHC convened national experts, patient advocates, and industry leaders to probe discuss the challenge diabetes poses to our nation and especially to diverse populations facing significant social and environmental challenges. The participants, listed below, urged an effort that will use data to help primary care practices and communities engage in strategic planning and improvement activities that will help the most challenged diabetes population better engage in ambulatory care, enhancing outcomes, addressing social determinants, and avoiding unnecessary hospitalizations.

diabetes-blood-sugar-diabetic-medicine-46173

Diabetes Working Group

As a result, SHC has launched the Diabetes Working Group, as a public-private partnership to promote patient-centered and sustainable health care and outcomes for diverse diabetes populations in most need. Through a series of meetings, an updated Diabetes Index mapping the toll of diabetes, and the development of communications around the toll of diabetes in the U.S. and recommended strategies for improvement, this 3-year initiative will drive a community-based initiative, in which health care providers and advocates from hard hit communities will implement practice improvement and community change efforts to promote patient-centered care. The DWG is chaired by Bruce Taylor, and includes the following sponsors to date:  Ascensia, AstraZeneca, Dexcom, Eli Lilly and Company, Horizon Blue Cross Blue Shield, and Sanofi.  Sponsorship includes participation in bi-monthly conference calls, one in-person meeting, and input to the DWG’s activities. Corporate sponsorship is $25,000 per year.

First Regional Program: Brooklyn, NY Diabetes Equity Task Force

The first community initiative realizes a partnership of health leaders in Brooklyn, NY, including: the State University of New York (SUNY)-Downstate Medical Center, School of Public Health, Nursing School, the Arthur Ashe Institute for Urban Health, and Brooklyn Health Disparities Center. The team is working collaboratively to identify strategies for greater connection of the patients with diabetes to ongoing care, self-help support, and primary care treatment. The group is actively conducting a community assessment as it identifies the health care system and community leaders to participate in training session in early 2018.

Click Here To View or Download the Diabetes Working and Equity Task Force Group 1-Pager.

To join the Diabetes Working Group and bring the initiative to your community, contact us at lhall@shcllc.info

the-climate-reality-project-349094

Diabetes Index Roundtable Participants

Pamela Allweiss, MD, MSPH
Medical officer at Centers for Disease Control and Prevention, Division of Diabetes Translation
Rita R. Kalyani, MD, MHS
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Marie T. Brown, MD
Senior Physician Advisor, Physician Satisfaction and Practice Sustainability Group, AMA Associate Professor, Rush Medical College
Rush University Medical Center
Alina Kolomeyer, PharmD
Post-Doctoral Fellow, North America Public Affairs
Sanofi
John D. Couk, MD
Chief Medical Officer
Louisiana State University Health Care Services Division
Assistant Professor of Emergency Medicine
Beth Mitchell, MPH, BSN, RN
Research Scientist, Global Patient Outcomes and Real World Evidence, Diabetes
Eli Lilly and Company
Jaime Davidson, MD
Clinical Professor of Medicine, University of Texas Southwestern Medical School, Dallas
Anna Norton, MS
CEO, DiabetesSisters
Keith C. Ferdinand, MD
Professor
Tulane University School of Medicine
Markus Ott
Global Head Market Access & Policy Ascensia DC
James Flanagan
Ascensia Diabetes Care
Christopher G. Parkin
President,
CGParkin Communications, Inc.
Emily C. Freeman, MSc, PhD
Senior Research Scientist, Global Patient Outcomes and Real World Evidence Patient Focused Outcomes- Center of Expertise Eli Lilly and Company
Gary A. Puckrein, PhD
CEO and President
National Minority Quality Forum
Founder, Sustainable Healthy Communities, LLC
James R. Gavin III, MD, PhD
CEO and Chief Medical Officer of Healing Our Village, Inc
Clinical Professor of Medicine at Emory University School of Medicine
Bernard M. Rosof, MD
President and CEO, Sustainable Healthy Communities, LLC
CEO of Quality in Health Care Advisory Group
Laura Lee Hall, PhD
Chief Operating Officer and Executive Vice President Sustainable Healthy Communities, LLC
Bruce T. Taylor
Director of Government Affairs and Market Access
Dexcom
Jennal L. Johnson, MS, FNP, CDE, BC-ADM, CDTC
Principal Research Scientist
Eli Lilly and Company
Gloria A. Wilder, MD
Vice President
Centene Corporation
Simone Karp, RPh Group Vice President Premier, Inc. Larisa Yedigarova, MD, PhD
US Medical Director – Cardiovascular Amgen US Medical Organization
champinIMIN